Literature DB >> 20736981

Thrombotic microangiopathy: atypical HUS: current diagnostic and therapeutic approaches.

Alejandra Rosales, Magdalena Riedl, Lothar B Zimmerhackl.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20736981     DOI： 10.1038/nrneph.2010.98

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome.

Authors:  Lothar Bernd Zimmerhackl; Johannes Hofer; Gérard Cortina; Walter Mark; Reinhard Würzner; Therese C Jungraithmayr; Gus Khursigara; Kay O Kliche; Wolfgang Radauer
Journal:  N Engl J Med       Date:  2010-05-06       Impact factor: 91.245

2.  Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.

Authors:  Jessica Caprioli; Marina Noris; Simona Brioschi; Gaia Pianetti; Federica Castelletti; Paola Bettinaglio; Caterina Mele; Elena Bresin; Linda Cassis; Sara Gamba; Francesca Porrati; Sara Bucchioni; Giuseppe Monteferrante; Celia J Fang; M K Liszewski; David Kavanagh; John P Atkinson; Giuseppe Remuzzi
Journal:  Blood       Date:  2006-04-18       Impact factor: 22.113

Review 3.  Atypical hemolytic-uremic syndrome.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

Review 4.  A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders.

Authors:  N Besbas; D Karpman; D Landau; C Loirat; W Proesmans; G Remuzzi; G Rizzoni; C M Taylor; N Van de Kar; L B Zimmerhackl
Journal:  Kidney Int       Date:  2006-06-14       Impact factor: 10.612

Review 5.  Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.

Authors:  Anna Richards; M Kathryn Liszewski; David Kavanagh; Celia J Fang; Elizabeth Moulton; Veronique Fremeaux-Bacchi; Giuseppe Remuzzi; Marina Noris; Timothy H J Goodship; John P Atkinson
Journal:  Mol Immunol       Date:  2006-08-01       Impact factor: 4.407

6.  Terminal complement complex (C5b-9) in children with recurrent hemolytic uremic syndrome.

Authors:  Friederike Prüfer; Johanna Scheiring; Sabine Sautter; Dorthe B Jensen; Ruth Treichl; Reinhard Würzner; L Bernd Zimmerhackl
Journal:  Semin Thromb Hemost       Date:  2006-03       Impact factor: 4.180

7.  The role of complement inhibition in PNH.

Authors:  Peter Hillmen
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2008

8.  von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.

Authors:  Giuseppe Remuzzi; Miriam Galbusera; Marina Noris; Maria Teresa Canciani; Erica Daina; Elena Bresin; Silvia Contaretti; Jessica Caprioli; Sara Gamba; Piero Ruggenenti; Norberto Perico; Pier Mannuccio Mannucci
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

9.  Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom.

Authors:  C Mark Taylor; Sam Machin; Stephen J Wigmore; Tim H J Goodship
Journal:  Br J Haematol       Date:  2009-10-11       Impact factor: 6.998

Review 10.  Complement and the atypical hemolytic uremic syndrome in children.

Authors:  Chantal Loirat; Marina Noris; Véronique Fremeaux-Bacchi
Journal:  Pediatr Nephrol       Date:  2008-07-02       Impact factor: 3.714
  10 in total
  5 in total

Review 1.  Atypical hemolytic uremic syndrome.

Authors:  Chantal Loirat; Véronique Frémeaux-Bacchi
Journal:  Orphanet J Rare Dis       Date:  2011-09-08       Impact factor: 4.123

Review 2.  Thrombotic microangiopathy and associated renal disorders.

Authors:  Thomas Barbour; Sally Johnson; Solomon Cohney; Peter Hughes
Journal:  Nephrol Dial Transplant       Date:  2012-07       Impact factor: 5.992

Review 3.  Atypical hemolytic-uremic syndrome: a case report and literature review.

Authors:  Arsalan Rafiq; Hassan Tariq; Naeem Abbas; Roopalekha Shenoy
Journal:  Am J Case Rep       Date:  2015-02-24

Review 4.  Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome.

Authors:  Hajeong Lee; Eunjeong Kang; Hee Gyung Kang; Young Hoon Kim; Jin Seok Kim; Hee-Jin Kim; Kyung Chul Moon; Tae Hyun Ban; Se Won Oh; Sang Kyung Jo; Heeyeon Cho; Bum Soon Choi; Junshik Hong; Hae Il Cheong; Doyeun Oh
Journal:  Korean J Intern Med       Date:  2020-01-02       Impact factor: 2.884

5.  Differentiating scleroderma renal crisis from other causes of thrombotic microangiopathy in a postpartum patient.

Authors:  Muaz Abudiab; Megan L Krause; Mary E Fidler; Karl A Nath; Suzanne M Norby
Journal:  Clin Nephrol       Date:  2013-10       Impact factor: 0.975
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.